2017 CPIC指南: HLA 基因型和卡马西平以及奥卡西平的应用(更新版)

2018-02-02 临床药物基因组学实施联盟 Clin Pharmacol Ther. 2018 Feb 2.

2018年2月,临床药物基因组学实施联盟(CPIC)发布了关于 HLA 基因型和卡马西平以及奥卡西平的应用指南2017更新版。 人白细胞抗原(HLA)基因变异芳香类抗惊厥要特定的皮肤不良反应相关,本文的主要目的是解释HLA-B*15:02 和 HLA-A*31:01基因型导致结果指导卡马西平和奥卡西平的使用。

中文标题:

2017 CPIC指南: HLA 基因型和卡马西平以及奥卡西平的应用(更新版)

英文标题:

Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update.

发布日期:

2018-02-02

简要介绍:

2018年2月,临床药物基因组学实施联盟(CPIC)发布了关于 HLA 基因型和卡马西平以及奥卡西平的应用指南2017更新版。

人白细胞抗原(HLA)基因变异芳香类抗惊厥要特定的皮肤不良反应相关,本文的主要目的是解释HLA-B*15:02 和 HLA-A*31:01基因型导致结果指导卡马西平和奥卡西平的使用。

 

拓展指南:卡马西平相关指南:

相关资料下载:
[AttachmentFileName(sort=100, fileName=2017 CPIC指南: HLA 基因型和卡马西平以及奥卡西平的应用(更新版))] GetToolGuiderByIdResponse(projectId=1, id=141331c001556600, title=2017 CPIC指南: HLA 基因型和卡马西平以及奥卡西平的应用(更新版), enTitle=Clinical Pharmacogenetics Implementation Consortium Guideline for HLA Genotype and Use of Carbamazepine and Oxcarbazepine: 2017 Update., guiderFrom=Clin Pharmacol Ther. 2018 Feb 2., authorId=null, author=, summary=2018年2月,临床药物基因组学实施联盟(CPIC)发布了关于 HLA 基因型和卡马西平以及奥卡西平的应用指南2017更新版。 人白细胞抗原(HLA)基因变异芳香类抗惊厥要特定的皮肤不良反应相关,本文的主要目的是解释HLA-B*15:02 和 HLA-A*31:01基因型导致结果指导卡马西平和奥卡西平的使用。 , cover=, journalId=null, articlesId=null, associationId=1236, associationName=临床药物基因组学实施联盟, associationIntro=, copyright=0, guiderPublishedTime=Fri Feb 02 00:00:00 CST 2018, originalUrl=, linkOutUrl=, content=<P>2018年2月,临床药物基因组学实施联盟(CPIC)发布了关于 HLA 基因型和卡马西平以及奥卡西平的应用指南2017更新版。 <BR><BR>人白细胞抗原(HLA)基因变异芳香类抗惊厥要特定的皮肤不良反应相关,本文的主要目的是解释HLA-B*15:02 和 HLA-A*31:01基因型导致结果指导卡马西平和奥卡西平的使用。</P> <P> </P>拓展指南:<strong>与<font color=red>卡马西平</font>相关指南:</strong><br><ul><li><a href="http://www.medsci.cn/guideline/show_article.do?id=141331c001556600" title="2017 CPIC指南: HLA 基因型和卡马西平以及奥卡西平的应用(更新版)" target=_blank>2017 CPIC指南: HLA 基因型和卡马西平以及奥卡西平的应用(更新版)</a></li> 更多信息请点击:<a href="http://www.medsci.cn/guideline/list.do?q=%E5%8D%A1%E9%A9%AC%E8%A5%BF%E5%B9%B3" target=_blank>有关卡马西平更多指南</a></ul>, tagList=[TagDto(tagId=4804, tagName=HLA), TagDto(tagId=10327, tagName=基因型), TagDto(tagId=9551, tagName=卡马西平), TagDto(tagId=9185, tagName=奥卡西平)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=null, articleKeyword=null, articleKeywordNum=null, guiderKeywordId=null, guiderKeyword=null, guiderKeywordNum=null, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=0, opened=0, paymentType=null, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=8664, appHits=197, showAppHits=0, pcHits=6435, showPcHits=3595, likes=119, shares=2, comments=4, approvalStatus=1, publishedTime=Sat Feb 17 19:41:04 CST 2018, publishedTimeString=2018-02-02, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=1, createdBy=null, createdName=qiushida2, createdTime=Sat Feb 17 19:41:04 CST 2018, updatedBy=null, updatedName=null, updatedTime=Sat Jan 06 06:38:10 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=100, fileName=2017 CPIC指南: HLA 基因型和卡马西平以及奥卡西平的应用(更新版))])
2017 CPIC指南: HLA 基因型和卡马西平以及奥卡西平的应用(更新版)
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=289740, encodeId=a522289e40ad, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Wed Feb 21 19:52:40 CST 2018, time=2018-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288774, encodeId=ab6a288e74d8, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Feb 18 00:16:42 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288757, encodeId=4615288e57be, content=2018年2月.临床药物基因组学实施联盟(CPIC)发布了关于 HLA 基因型和卡马西平以及奥卡西平的应用指南2017更新版.? 人白细胞抗原(HLA)基因变异芳香类抗惊厥要特定的皮肤不良反应相关.本文的主要目的是解释HLA-B*15:02 和 HLA-A*31:01基因型导致结果指导卡马西平和奥卡西平的使用., beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Feb 17 22:36:48 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288730, encodeId=03e0288e300b, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Feb 17 21:01:33 CST 2018, time=2018-02-17, status=1, ipAttribution=)]
    2018-02-21 131****1460

    学习了受益匪浅

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=289740, encodeId=a522289e40ad, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Wed Feb 21 19:52:40 CST 2018, time=2018-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288774, encodeId=ab6a288e74d8, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Feb 18 00:16:42 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288757, encodeId=4615288e57be, content=2018年2月.临床药物基因组学实施联盟(CPIC)发布了关于 HLA 基因型和卡马西平以及奥卡西平的应用指南2017更新版.? 人白细胞抗原(HLA)基因变异芳香类抗惊厥要特定的皮肤不良反应相关.本文的主要目的是解释HLA-B*15:02 和 HLA-A*31:01基因型导致结果指导卡马西平和奥卡西平的使用., beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Feb 17 22:36:48 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288730, encodeId=03e0288e300b, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Feb 17 21:01:33 CST 2018, time=2018-02-17, status=1, ipAttribution=)]
    2018-02-18 1dd8c52fm63(暂无匿称)

    了解了解.继续关注

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=289740, encodeId=a522289e40ad, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Wed Feb 21 19:52:40 CST 2018, time=2018-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288774, encodeId=ab6a288e74d8, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Feb 18 00:16:42 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288757, encodeId=4615288e57be, content=2018年2月.临床药物基因组学实施联盟(CPIC)发布了关于 HLA 基因型和卡马西平以及奥卡西平的应用指南2017更新版.? 人白细胞抗原(HLA)基因变异芳香类抗惊厥要特定的皮肤不良反应相关.本文的主要目的是解释HLA-B*15:02 和 HLA-A*31:01基因型导致结果指导卡马西平和奥卡西平的使用., beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Feb 17 22:36:48 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288730, encodeId=03e0288e300b, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Feb 17 21:01:33 CST 2018, time=2018-02-17, status=1, ipAttribution=)]
    2018-02-17 有备才能无患

    2018年2月.临床药物基因组学实施联盟(CPIC)发布了关于 HLA 基因型和卡马西平以及奥卡西平的应用指南2017更新版.? 人白细胞抗原(HLA)基因变异芳香类抗惊厥要特定的皮肤不良反应相关.本文的主要目的是解释HLA-B*15:02 和 HLA-A*31:01基因型导致结果指导卡马西平和奥卡西平的使用.

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=289740, encodeId=a522289e40ad, content=学习了受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/ajNVdqHZLLDicHg2ldsSNmib46PmdzpO7CQEmPjuULp1v45zPWwMYhrnXgvl3OtmUCZSQfgITWn96X9moL94nUGA/0, createdBy=28072041016, createdName=131****1460, createdTime=Wed Feb 21 19:52:40 CST 2018, time=2018-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288774, encodeId=ab6a288e74d8, content=了解了解.继续关注, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=93f31631454, createdName=1dd8c52fm63(暂无匿称), createdTime=Sun Feb 18 00:16:42 CST 2018, time=2018-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288757, encodeId=4615288e57be, content=2018年2月.临床药物基因组学实施联盟(CPIC)发布了关于 HLA 基因型和卡马西平以及奥卡西平的应用指南2017更新版.? 人白细胞抗原(HLA)基因变异芳香类抗惊厥要特定的皮肤不良反应相关.本文的主要目的是解释HLA-B*15:02 和 HLA-A*31:01基因型导致结果指导卡马西平和奥卡西平的使用., beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/NUyjXTCJjo7cJ6ejWUr2nIia8qOvAKNdLHr32Df6G8iaoaOx6pHaoiacwp26DaslxZHCGbibZhhCGven4rvmWP60GahtzgFjgCjR/0, createdBy=6b111703011, createdName=有备才能无患, createdTime=Sat Feb 17 22:36:48 CST 2018, time=2018-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=288730, encodeId=03e0288e300b, content=学习.谢谢分享., beContent=null, objectType=guider, channel=null, level=null, likeNumber=78, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/xkvRjYnJzzRJ2R0y7VhicibvkjPWHjIMmu4ZpKnE9cWAu4lVicS3uDUCfF4M4JWvrkrYfpb2KehPV0Ee29tPqyPEebBUibiaKhnvD/0, createdBy=f8412001184, createdName=惠映实验室, createdTime=Sat Feb 17 21:01:33 CST 2018, time=2018-02-17, status=1, ipAttribution=)]
    2018-02-17 惠映实验室

    学习.谢谢分享.

    0